The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastoma.

Re-analysis of publicly available microarray data revealed a highly significant upregulation of KDM1A mRNA in primary medulloblastomas compared to normal human cerebellum (Figure 1 a) [ 22 , 23 ].

also in 132,142 other papers